A multicenter, multicohort, phase II study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer

被引:0
|
作者
Yoshino, T. [1 ]
Siena, S. [2 ]
Dalal, R. [3 ]
Okuda, Y. [4 ]
Yamamoto, E. [5 ]
Grothey, A. [6 ]
机构
[1] Natl Canc Ctr Hosp East, Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[2] Univ Milan, Niguarda Canc Ctr, Milan, Italy
[3] Daiichi Sankyo Inc, Med, Basking Ridge, NJ USA
[4] Daiichi Sankyo Co Ltd, Biostat & Data Management Dept, Chuo Ku, Tokyo, Japan
[5] Daiichi Sankyo Co Ltd, Clin Dev, Chuo Ku, Tokyo, Japan
[6] Mayo Clin, Canc Ctr, Dept Med Oncol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
146TiP
引用
收藏
页码:45 / 45
页数:1
相关论文
empty
未找到相关数据